AMAlly Murji

Ally Murji

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ally Murji has a total of 201 co-authors. Here are the top co-authors by number of shared publications:

  • John Matelski

    Biostatistics Research Unit, University Health Network, Toronto, ON, Canada

    9 shared publications
  • Lindsay Shirreff

    Department of Obstetrics and Gynecology, University of Toronto, Ontario, Canada; Department of Obstetrics and Gynecology, Mount Sinai Hospital, Toronto, Ontario, Canada

    8 shared publications
  • Ari P. Sanders

    Department of Obstetrics and Gynecology, University of Calgary, Peter Lougheed Centre, Calgary, Alberta, Canada

    6 shared publications
  • Chris Walsh

    Library Services, Mount Sinai Hospital, Toronto, ON, Canada

    5 shared publications
  • Andrew Zakhari

    4 shared publications
  • John Kingdom

    Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada

    4 shared publications

Latest Publications

  • Socioeconomic Disparities in Surgical Wait Times for Elective Hysterectomy

    by Sarah Shamiya, Nupur Dogra, Aliya Allen-Valley, Karen Rai, Canyucel Gungor, Amanda Cipolla, Tiffany Zigras, Elizabeth Miazga, Laura C. Rosella, Ally Murji

  • Assessment of the accuracy and readability of artificial generative intelligence for patient questions on heavy menstrual bleeding

    by Olivia Carere, Lauren Clarfield, M. Alix Murphy, Azra Shivji, Chelsie Warshafsky, Corey Sermer, Kinshuk Kumar, Ally Murji

  • Open Access

    Appraisal of international, patient‐facing resources on heavy menstrual bleeding

    by Olivia Carere, Lauren Clarfield, Lacey Brennan, Hilary O. D. Critchley, Jade Desilets, Laura Diamond, Yasushi Hirota, Kinshuk Kumar, Sarah Maheux‐Lacroix, Kristen A. Matteson, et al.

    This study aimed to systematically evaluate the quality of widely accessible, English language, patient‐facing resources on heavy menstrual bleeding (HMB), identifying strengths, gaps, and opportunities for improvement. Resources were obtained from (1) a systematic Google Trends‐informed Google search and (2) submissions from subject matter experts. Eligible resources were independently reviewed and scored using validated tools for credibility (QUEST), aesthetics (modified Abbott's scale), and readability. To evaluate clinical utility, resources were graded using a tool designed by international experts for comprehensiveness and accuracy across six domains. Inter‐rater reliability was assessed with the intraclass correlation coefficient (ICC) and Cohen's kappa. Of 353 resources identified, 63 met the inclusion criteria. Mean QUEST score (maximum = 28) was 18.7 ± 5.1, with 4/63 (6%) resources meeting all credibility criteria. Mean aesthetics score (maximum = 7) was 5.3 ± 1.1, with only 15/63 (24%) resources with graphics. Most resources (40/63, 64%) were written at a grade 10–12 reading level. Mean comprehensiveness score (maximum = 6) was 4.6 ± 0.8, with gaps most often observed in advice on when to seek emergency care and information about iron deficiency. Mean accuracy score (maximum = 12) was 8.0 ± 2.3, with only 3/63 (13%) resources containing completely accurate content. There was moderate‐to‐substantial agreement across reviewers (ICC = 0.60–65 for aesthetics credibility; κ = 0.38–49 for accuracy comprehensiveness). In conclusion, most online resources accessed by patients are moderately credible, difficult to read, and underutilize figures. Content gaps exist mainly related to education on safety and iron deficiency. Very few resources are entirely accurate. We recommend targeted revisions to patient education resources to better inform and empower patients experiencing HMB.

  • Effect of Medical Therapies for Endometriosis on Bone Health

    by Jade Md Desilets, Rosa Lakabi, Alisha MD Olsthoorn, John Msc Matelski, Chris Mi Walsh, Ally Md Murji, Elizabeth Md Miazga

    OBJECTIVE: To evaluate the effect of endometriosis medical therapies on bone mineral density (BMD). DATA SOURCES: Electronic databases were searched from inception to July 2025 for clinical studies reporting the effect of hormonal treatments for endometriosis on BMD. METHODS OF STUDY SELECTION: Eligible studies included randomized controlled trials (RCTs) and prospective and retrospective cohort studies involving women of reproductive age. Interventions assessed were gonadotropin-releasing hormone (GnRH) agonists with add-back therapy, dienogest, GnRH antagonists, and depot medroxyprogesterone acetate (DMPA). Risk of bias was evaluated with the Cochrane Risk of Bias Tool to evaluate RCTs, the Risk of Bias in Non-Randomized Studies of Interventions tool for nonrandomized trials, and the Newcastle–Ottawa Scale for cohort studies. A total of 1,153 studies were screened, of which 37 met inclusion criteria. TABULATION, INTEGRATION, AND RESULTS: Pooled analysis of GnRH agonist showed a decrease in BMD at 6 months (−0.89%, 95% CI, −1.45 to −0.33, I 2 =20.3%, 11 studies) and at 12 months (−1.50%, 95% CI, −2.68 to −0.31, I 2 =40.5%, four studies). Subgroup analysis by GnRH agonist type decreased heterogeneity and showed that at 6 months both leuprolide (−1.33%, 95% CI, −1.92 to −0.74, I 2 =0%, six studies) and goserelin (−0.42%, 95% CI, −1.00 to 0.16, I 2 =11%, five studies) with add-back decreased BMD. Dienogest was associated with lower BMD at 6 months (−0.83%, 95% CI, −1.52 to −0.15, I 2 =76.8%, six studies) and 12 months (−1.91%, 95% CI, −2.58 to −1.24. I 2 =83.7%, four studies); however, there were high heterogeneity and inconsistency between studies. GnRH antagonist decreased BMD at 6 months (−2.17%, 95% CI, −3.44 to −0.90, I 2 =97.3%, five studies), although most studies lacked add-back therapy. Data from four studies on DMPA could not be meta-analyzed. Risk of bias was low in studies included in the analysis. CONCLUSION: Hormonal suppression for endometriosis treatment is associated with a decrease in BMD after 12 months of use, with each medical therapy having a unique effect. The clinical significance of these findings remains uncertain, highlighting the need for expert consensus for bone health management in patients on long-term hormonal therapy. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42024580675.


  • Top Cited Papers
    Open Access

    Diagnosis and classification of uterine fibroids

    by Rosa Lakabi, Sebastian Harth, Ivo Meinhold‐Heerlein, Alisha V. Olsthoorn, Malcolm G. Munro, Ally Murji

    Uterine fibroids, or leiomyomas, are benign uterine tumors with a lifetime prevalence of approximately 75%. While only a minority become symptomatic, their impact on quality of life remains profound owing to heavy menstrual bleeding, bulk symptoms, and reproductive dysfunction. Interestingly, fibroids are not reliably diagnosed on physical examination, nor can their impact be predicted through palpation. Consequently, the diagnosis and phenotypic categorization of uterine fibroids relies primarily on imaging to guide subsequent clinical management. Ultrasound should be the first‐line diagnostic modality, and magnetic resonance imaging should be reserved for complex cases and/or surgical planning. Adherence to standardized structured reporting across imaging modalities is critical to improve diagnostic accuracy, differentiate fibroids from conditions such as adenomyosis or malignancies, predict therapeutic responses, and plan surgical interventions. Imaging reports should follow the FIGO classification system for uterine fibroids, to enable a standardized description of their relationship to the endometrium, myometrium, and uterine serosa.


  • Open Access

    Appraisal of online health information on intravenous iron: Are patients well‐informed?

    by Grace Zhou, Ally Murji, Anna Kobylianskii, Alysha Nensi, Leslie Po, Carmen McCaffrey, Lindsay Shirreff

    This study aimed to evaluate the quality, content, and readability of top‐listed websites on intravenous (IV) iron. We conducted online searches for the term “iron infusion” using Google, Bing, and Yahoo. The search term was determined based on Google Trends data for March 2025. Five gynecologists independently reviewed the websites using the DISCERN instrument, Journal of the American Medical Association (JAMA) benchmarks, and Abbott's Scale. Credibility and readability were further assessed using the Health on the Net (HON) Foundation Code of Conduct Certification, the Simple Measure of Gobbledygook (SMOG), the Flesch–Kincaid Grade Level (FKGL), and the Flesch–Kincaid Read Ease formula (FRES). A total of 25 websites were included. The mean DISCERN score was moderate (2.9 ± 0.9 out of 5), with only three websites (12%) providing excellent quality information. Seven (28%) websites were classified as having poor to very poor quality information. The mean JAMA score was low (2.1 ± 1.3 out of 4), and only three websites (12%) met all benchmarks. The overall content score on Abbott's scale was low (45.4 ± 16.1 out of 106). The average authorship score (2.1 ± 1.2 out of 3) and esthetics rating (5.4 ± 1.2 out of 10) were moderate. Notably, 21 (84%) websites were not certified by the HONcode. Readability levels were poor, as reflected by the FRES (38.1 ± 16.9 out of 100), the FKGL (equivalent grade, 12.4 ± 2.8), and the SMOG (equivalent grade, 12.7 ± 2.4). Although information on IV iron is widely available online, its overall quality and content are generally poor and not easily accessible to the public. This underscores the opportunity for knowledge translation efforts aimed at developing online resources that are both accurate and understandable.


  • Open Access

    Cesarean Scar Niche and Pelvic Pain: A Systematic Review and Meta-Analysis

    by Naomi Min, Peter Thiel, Meghan McGrattan, Emiel Post Uiterweer, John Matelski, Chris Walsh, Judith Huirne, Ally Murji


  • Ending the taboo on periods and period problems

    by Hilary O. D. Critchley, Ian Roberts, Ally Murji, Michelle Lavin, Lesley Regan, Michael K. Georgieff, Malcolm G. Munro